GSK Rides E-Commerce Wave In Choppy COVID Waters
Executive Summary
GSK saw investments in e-commerce paying off in 2020 as the firm was able to meet increased demand for consumer health products during the pandemic while many shoppers remained indoors.
You may also be interested in...
With Spring's Arrival, OTC Allergy Ad Campaigns Bloom In US For Claritin, Flonase
Bayer launches multi-year campaign “Outsideologist Project” for Claritin to offer parents fun ways to get their children outside. GSK’s “Change the Game” campaign for Flonase as official allergy relief partner of MLB has new spokesman.
Q1 Consumer Health Earnings Preview: GSK, Sanofi And Bayer
Likely talking points when three of the biggest global consumer health players report Q1 results include: GSK's separation plan and the influence of a new major investor; Sanofi's program to divest over half of its OTC brands; and Bayer's ability to sustain higher sales of dietary supplements post-COVD-19.
GSK Consumer Separation On Track For Summer '22
COVID-19 has not held back GSK's preparations to create the world's largest standalone consumer health business, with CEO Emma Walmsley confirming separation is on track for summer next year.